Cardinal Health Inc. diskutieren
Cardinal Health Inc.
WKN: 880206 / Symbol: CAH / Name: Cardinal Health / Aktie / Lebensmittel- & Medikamentenhandel / Large Cap /
168,85 €
0,27 %
Cardinal Health, Inc. (NYSE: CAH) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Barclays PLC from $117.00 to $133.00. They now have an "overweight" rating on the stock.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at UBS Group AG from $134.00 to $139.00. They now have a "buy" rating on the stock.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Morgan Stanley from $119.00 to $127.00. They now have an "overweight" rating on the stock.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) is now covered by analysts at Mizuho. They set an "outperform" rating and a $139.00 price target on the stock.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Morgan Stanley from $127.00 to $136.00. They now have an "overweight" rating on the stock.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $140.00 price target on the stock.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Morgan Stanley from $136.00 to $142.00. They now have an "overweight" rating on the stock.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Mizuho from $142.00 to $150.00. They now have an "outperform" rating on the stock.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Bank of America Co. from $150.00 to $155.00. They now have a "buy" rating on the stock.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at UBS Group AG from $150.00 to $160.00. They now have a "buy" rating on the stock.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Robert W. Baird from $156.00 to $170.00. They now have an "outperform" rating on the stock.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Morgan Stanley from $142.00 to $166.00. They now have an "overweight" rating on the stock.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $179.00 price target on the stock, up previously from $136.00.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Bank of America Co. from $165.00 to $170.00. They now have a "buy" rating on the stock.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Evercore ISI from $175.00 to $180.00. They now have an "outperform" rating on the stock.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Morgan Stanley from $166.00 to $181.00. They now have an "overweight" rating on the stock.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Morgan Stanley from $181.00 to $190.00. They now have an "overweight" rating on the stock.
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target lowered by analysts at Evercore ISI from $200.00 to $190.00. They now have an "outperform" rating on the stock.
Ratings data for CAH provided by MarketBeat
Neueste Beiträge
Morgan_Stanley in Hasbro Inc. diskutieren